Aadit Shah joined The Column Group as a Swanson Fellow in 2022 while in training for his MD at Stanford University. Aadit holds a BS in Biomedical Engineering from Washington University and an MPhil in Bioscience Enterprise from the University of Cambridge. While completing these degrees, he conducted 4 years of immunology/infectious disease research that resulted in publications in Nature and Cell. He also led the development of a non-mydriatic retinal imager through to acquisition. While at Cambridge and Stanford, he gained exposure to operating and investing experience in therapeutics (particularly immuno-oncology and genetic medicines) with prior work spanning Flagship Pioneering, Tessera Therapeutics, and 5AM Ventures. As an advocate for the larger student innovation community, Aadit oversaw the national network of biomedical incubators: Sling Health. As National Network President, he supported more than 1000 students across 15 institutions and reported outcomes twice in Nature Biotechnology.